[New - 5 Musts To Achieve Covid-19 Independence](https://wbbsec.com/news/sars-cov-2/)
[New - 5 Musts To Achieve Covid-19 Independence](https://wbbsec.com/news/sars-cov-2/)
powered by bulletin
  •   (858) 592-9901
  •   [email protected]
WBB Securities, LLCWBB Securities, LLC
  • Our Firm
    • The Team
    • Advisor Services
      • About the Broker-Dealer & RIA
  • Investment Banking
    • Life Sciences Sectors
    • M&A and Strategic Advisory
    • Institutional Sales
    • Equity Capital Markets
  • Research
    • Research Samples
  • News
    • Press Releases
    • Opinions & Features
    • SARS-CoV-2
    • Video Presentations
  • Asset Management
  • WBB Research Institute
WBB Securities, LLCWBB Securities, LLC
  • Our Firm
    • The Team
    • Advisor Services
      • About the Broker-Dealer & RIA
  • Investment Banking
    • Life Sciences Sectors
    • M&A and Strategic Advisory
    • Institutional Sales
    • Equity Capital Markets
  • Research
    • Research Samples
  • News
    • Press Releases
    • Opinions & Features
    • SARS-CoV-2
    • Video Presentations
  • Asset Management
  • WBB Research Institute
WBB Securities, LLCWBB Securities, LLC
  • Our Firm
    • The Team
    • Advisor Services
      • About the Broker-Dealer & RIA
  • Investment Banking
    • Life Sciences Sectors
    • M&A and Strategic Advisory
    • Institutional Sales
    • Equity Capital Markets
  • Research
    • Research Samples
  • News
    • Press Releases
    • Opinions & Features
    • SARS-CoV-2
    • Video Presentations
  • Asset Management
  • WBB Research Institute

Press Releases

WBB SECURITIES ACTS AS CO-MANAGER IN A $45 MILLION PUBLIC OFFERING, PRE-FUNDED WARRANTS AND WARRANTS FOR SCYNEXIS, INC.

By:WBB SecuritiesPosted: Apr 26th, 2022In: Press Releases

WBB Securities acted as co-manager for a public offering, pre-funded warrants and warrants for SCYNEXIS, Inc.

Read More about WBB SECURITIES ACTS AS CO-MANAGER IN A $45 MILLION PUBLIC OFFERING, PRE-FUNDED WARRANTS AND WARRANTS FOR SCYNEXIS, INC.

WBB Securities and WBB Research Institute Sponsors Demy-Colton’s Virtual Salon: Getting to the Next Normal: A Roadmap for Living with COVID

By:WBB SecuritiesPosted: Mar 17th, 2022In: Press Releases

The Salon will feature three of the authors of a new, definitive report on the future of COVID, titled Getting to the Next Normal: A Roadmap for Living with COVID.

Read More about WBB Securities and WBB Research Institute Sponsors Demy-Colton’s Virtual Salon: Getting to the Next Normal: A Roadmap for Living with COVID

Steve Brozak, President of WBB Securities participated in a Biotech Showcase session titled, Covid: What Happens Next?

By:WBB SecuritiesPosted: Jan 12th, 2022In: Press Releases

Steve Brozak, President of WBB Securities today participated in a Biotech Showcase session titled, Covid: What Happens Next?

Read More about Steve Brozak, President of WBB Securities participated in a Biotech Showcase session titled, Covid: What Happens Next?

WBB Securities Sponsors The Annual Biotech Showcase: The Investor Conference for Innovations 2022

By:WBB SecuritiesPosted: Jan 10th, 2022In: Press Releases

WBB Securities is a sponsor of this year’s Biotech Showcase.

Read More about WBB Securities Sponsors The Annual Biotech Showcase: The Investor Conference for Innovations 2022

WBB Securities President Steve Brozak will Moderate a panel at the BioFuture Conference on Wednesday, October 6, 2021

By:WBB SecuritiesPosted: Oct 5th, 2021In: Press Releases

Steve Brozak, DMH, Managing Partner and President of WBB Securities will moderate a panel at BioFuture on October 6, 2021.

Read More about WBB Securities President Steve Brozak will Moderate a panel at the BioFuture Conference on Wednesday, October 6, 2021

WBB Securities President Steve Brozak Gives A SARS-CoV-2 Presentation Followed By A Q&A Session At Columbia University.

By:WBB SecuritiesPosted: May 19th, 2021In: Press Releases

Steve Brozak, the Managing Partner and President of WBB Securities gave a comprehensive presentation about SARS-CoV-2 at Columbia University...

Read More about WBB Securities President Steve Brozak Gives A SARS-CoV-2 Presentation Followed By A Q&A Session At Columbia University.

WBB Securities Sponsors Demy-Colton Virtual Salon “Sepsis: A Critical Healthcare Burden Needing Rapid Diagnoses to Improve Patient Outcomes”

By:WBB SecuritiesPosted: Mar 25th, 2021In: Press Releases

WBB Securities, sponsored a Demy-Colton Virtual Salon focused on the critical need for point-of-care...

Read More about WBB Securities Sponsors Demy-Colton Virtual Salon “Sepsis: A Critical Healthcare Burden Needing Rapid Diagnoses to Improve Patient Outcomes”

WBB Securities President Steve Brozak will moderate a Live Forum at Biotech Showcase today.

By:WBB SecuritiesPosted: Jan 6th, 2021In: Press Releases

Steve Brozak, Managing Partner and President of WBB Securities, LLC will moderate a live forum at Biotech Showcase on January 6, 2021.

Read More about WBB Securities President Steve Brozak will moderate a Live Forum at Biotech Showcase today.

WBB Securities Acts As Co-Manager In a $85 Million Public Offering, Pre-Funded Warrants and Warrants For SCYNEXIS, Inc.

By:WBB SecuritiesPosted: Dec 22nd, 2020In: Press Releases

WBB Securities Acts As Co-Manager In a $85 Million Public Offering...

Read More about WBB Securities Acts As Co-Manager In a $85 Million Public Offering, Pre-Funded Warrants and Warrants For SCYNEXIS, Inc.

WBB Securities Acts As Co-Manager In a $15.0 Million Public Offering For CohBar Inc.

By:WBB SecuritiesPosted: Aug 28th, 2020In: Press Releases

WBB Securities acted as co-manager for a public offering of CohBar Inc. on August 28, 2020...

Read More about WBB Securities Acts As Co-Manager In a $15.0 Million Public Offering For CohBar Inc.
Load More

Recent News

  • 5 Musts To Achieve Covid-19 Independence July 2, 2022
  • Lessons from earlier pandemics: Vaccine panel must discuss imprinting among infants and toddlers June 13, 2022
  • A Virtual Covid-19 Summit With Virtually No Chance Of Success May 12, 2022
  • WBB SECURITIES ACTS AS CO-MANAGER IN A $45 MILLION PUBLIC OFFERING, PRE-FUNDED WARRANTS AND WARRANTS FOR SCYNEXIS, INC. April 26, 2022
  • FDA’s Vaccine Panel Questions The Sustainability Of Our Covid-19 Strategy April 8, 2022

20 Commerce Dr.
Ste. 135
Cranford, NJ 07016

3111 Camino Del Rio N.
Ste. 400
San Diego, CA 92108

Copyright © 2021 WBB Securities, LLC. All Rights Reserved. Member FINRA/SIPC, BrokerCheck

  • Form CRS
  • Disclosures
  • Privacy Policy
Menu Bottom